Innovator IBD 50 ETF (NYSEARCA:FFTY) Shares Up 1.2% – Still a Buy?

Posted by Joseph Casey on Oct 6th, 2026

Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Free Report) shot up 1.2% during mid-day trading on Monday. The stock traded as high as $35.94 and last traded at $35.83. Approximately 9,000 shares changed hands during mid-day trading, a decline of 83% from the average daily volume of 52,622 shares. The stock had previously closed at $35.39.

Innovator IBD 50 ETF Stock Performance

The firm has a fifty day moving average price of $36.24 and a 200 day moving average price of $37.92. The stock has a market cap of $69.87 million, a PE ratio of 30.34 and a beta of 1.48.

Institutional Investors Weigh In On Innovator IBD 50 ETF

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Concurrent Investment Advisors LLC boosted its holdings in Innovator IBD 50 ETF by 11.1% in the second quarter. Concurrent Investment Advisors LLC now owns 63,128 shares of the company’s stock worth $3,349,000 after acquiring an additional 6,321 shares in the last quarter. WorthPointe LLC increased its holdings in shares of Innovator IBD 50 ETF by 18.3% during the second quarter. WorthPointe LLC now owns 24,412 shares of the company’s stock valued at $1,295,000 after acquiring an additional 3,771 shares in the last quarter. Kraematon Investment Advisors Inc. acquired a new position in shares of Innovator IBD 50 ETF during the second quarter valued at about $1,021,000. Royal Bank of Canada raised its position in shares of Innovator IBD 50 ETF by 3,222.5% in the 1st quarter. Royal Bank of Canada now owns 18,274 shares of the company’s stock valued at $611,000 after purchasing an additional 17,724 shares during the last quarter. Finally, Guardian Wealth Advisors LLC NC purchased a new position in shares of Innovator IBD 50 ETF in the 2nd quarter valued at approximately $507,000.

About Innovator IBD 50 ETF

(Get Free Report)

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.